31 – 40 of 69
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Increased levels of UCHL-1 in cerebrospinal fluid from patients with Alzheimer’s disease.
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Endokrina och diagnostiska aspekter på kognitiv svikt
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
The amyloid-β degradation pattern in plasma: A possible tool for clinical trials in Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
SWEDEHEART Annual Report 2012
(
- Contribution to journal › Article
-
Mark
Swedeheart : Annual Report 2013
2014)(
- Book/Report › Report
- 2013
-
Mark
Endocrine and diagnostic aspects of cognitive impairment with special reference to Alzheimer's disease
2013)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Reduced cerebrospinal fluid level of thyroxine in patients with Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Cerebrospinal Fluid (CSF) 25-Hydroxyvitamin D Concentration and CSF Acetylcholinesterase Activity Are Reduced in Patients with Alzheimer's Disease
(
- Contribution to journal › Article
-
Mark
The 2011 outcome from the Swedish Health Care Registry on Heart Disease (SWEDEHEART).
(
- Contribution to journal › Article
-
Mark
Serum but not Cerebrospinal Fluid levels of Insulin-Like Growth Factor-I (IGF-I) and IGF-Binding Protein-3 (IGFBP-3) are Increased in Alzheimer ́s Disease
2013) Endokrindagarna, 2013(
- Contribution to conference › Poster